JCM Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Murdoch, D. R.
Right arrow Articles by Chambers, S. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Murdoch, D. R.
Right arrow Articles by Chambers, S. T.

 Previous Article

Journal of Clinical Microbiology, January 1999, p. 281-281, Vol. 37, No. 1
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

LETTERS TO THE EDITOR

Sequence-Based Classification Scheme for the Genus Legionella Targeting the 5S rRNA Gene

    LETTER
Top
Letter
References

We read with interest the article by Ratcliff et al. (3) concerning a sequence-based classification of Legionella targeting the mip gene. We have used a similar classification system based on the smaller 5S rRNA gene (104 bp) which, while less discriminatory than the mip gene, enables species-specific identification of most Legionella species implicated in human disease.

Our classification scheme was constructed from the 5S rRNA sequences of type strains deposited in the GenBank database by Heidrich et al. (1, 4) and others. All species in the database, including eight species thus far isolated only from environmental sources, can be distinguished from each other, apart from L. longbeachae serogroup 2, L. dumoffii, and L. hackeliae, which have identical 5S rRNA sequences. Several other species exhibit differences of only one or two bases. However, L. pneumophila is easily distinguished from other species by a signature sequence at bp 61 to 63 (TTT). While the 5S rRNA genes of many L. pneumophila strains have been sequenced, the corresponding sequences for other species are currently based on only a few strains.

We have used this scheme to identify both Legionella isolates and Legionella DNA detected in urine and serum samples by PCR using the following methods. DNA from bacterial isolates was extracted by an alkaline lysis method, where 50 µl of bacterial suspension (109 CFU/ml) was added to 50 µl of 0.05 M NaOH, heated at 95°C for 15 min, and then neutralized by the addition of 10 µl of 1 M Tris (pH 7.7). Urine (200 µl) and serum (100 µl) samples were incubated in a 550-µl lysis solution containing 8.6 mM Tris (pH 8.3), 1.1 mM EDTA, 0.01% (wt/vol) glycogen, 0.9% (wt/vol) sodium dodecyl sulfate, and 0.45 mg of proteinase K/ml for 30 min at 56°C, and DNA was extracted with phenol and chloroform. The 5S rRNA gene was amplified by PCR (2) with M13-tailed primers. Products to be sequenced were purified by using a High Pure PCR Product Purification kit (Boehringer, Mannheim, Germany). Cycle sequencing reactions were performed by using a Thermo Sequenase fluorescence-labelled primer cycle sequencing kit with 7-deaza-dGTP (Amersham Life Science, Little Chalfont, United Kingdom) and IRD-41-labelled infrared M13 forward and reverse primers. Sequencing reaction products were analyzed on a LI-COR 4000L automated DNA sequencer (LI-COR Inc., Lincoln, Nebr.).

We have tested cultures of the following species using these methods: L. pneumophila serogroups 1 to 14, L. anisa, L. israelensis, L. birminghamensis, L. micdadei, L. longbeachae serogroup 1, L. wadsworthii, L. oakridgensis, L. dumoffii, L. jordanis, L. feelei serogroup 2, L. hackeliae, L. macearchernii, L. sainthelensi, and L. bozemanii serogroup 2. All results confirmed identifications by conventional methods. Of the nine wild strains tested (L. pneumophila [4], L. longbeachae [2], L. bozemanii [2], and L. feelei), the L. pneumophila strains showed 100% homology with the database, while the other species exhibited one or two base differences. This approach has also enabled us to identify to species level Legionella DNA detected in urine and serum samples from patients with pneumonia (unpublished data).

The 5S rRNA target has insufficient discriminatory power if genotyping Legionella species is the primary goal. However, this scheme may be useful for laboratories committed to a 5S rRNA PCR system, especially for the differentiation of L. pneumophila from other species.

    ACKNOWLEDGMENTS

We thank Luciano Matson, Aaron Jeffs, and the Cytogenetic and Molecular Oncology Unit, Department of Pathology, Christchurch School of Medicine, for assistance with sequencing.

Financial support was provided by a short-term study grant from the Royal Australasian College of Physicians.

    FOOTNOTES

* Present address: Division of Infectious Diseases and International Health, Box 3824, Duke University Medical Center, Durham, NC 27710. Phone: (919) 684-2660. Fax: (919) 684-8902. E-mail: murdo005{at}mc.duke.edu.

    REFERENCES
Top
Letter
References

1. Heidrich, B., F. Tiecke, P. N. Robinson, D. Steinhoff, F. J. Fehrenbach, and A. Rolfs. 1994. Automated direct sequencing of Legionella 5S rDNA. Med. Microbiol. Lett. 3:279-290.
2. Murdoch, D. R., E. J. Walford, L. C. Jennings, G. J. Light, M. I. Schousboe, A. Y. Chereshsky, S. T. Chambers, and G. I. Town. 1996. Use of the polymerase chain reaction to detect Legionella DNA in urine and serum samples from patients with pneumonia. Clin. Infect. Dis. 23:475-480[Medline].
3. Ratcliff, R. M., J. A. Lanser, P. A. Manning, and M. W. Heuzenroeder. 1998. Sequence-based classification scheme for the genus Legionella targeting the mip gene. J. Clin. Microbiol. 36:1560-1567[Abstract/Free Full Text].
4. Robinson, P. N., B. Heidrich, F. Tiecke, F. J. Fehrenbach, and A. Rolfs. 1996. Species-specific detection of Legionella using polymerase chain reaction and reverse dot-blotting. FEMS Microbiol. Lett. 140:111-119[Medline].
David R. Murdoch
Gillian J. Light
Lance C. Jennings
Microbiology Unit
Canterbury Health Laboratories
Christchurch, New Zealand
Stephen T. Chambers
Department of Infectious Diseases
Christchurch Hospital
Christchurch, New Zealand


Journal of Clinical Microbiology, January 1999, p. 281-281, Vol. 37, No. 1
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Murdoch, D. R.
Right arrow Articles by Chambers, S. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Murdoch, D. R.
Right arrow Articles by Chambers, S. T.


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS